On Friday, Neurogene Inc (NASDAQ: NGNE) was 22.63% up from the session before settling in for the closing price of $8.97. A 52-week range for NGNE has been $6.88 – $74.49.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -7.96%. With a float of $12.29 million, this company’s outstanding shares have now reached $14.85 million.
The extent of productivity of a business whose workforce counts for 107 workers is very important to gauge. In terms of profitability, gross margin is -1691.24%, operating margin of -8930.27%, and the pretax margin is -8123.68%.
Neurogene Inc (NGNE) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Neurogene Inc stocks. The insider ownership of Neurogene Inc is 17.67%, while institutional ownership is 93.70%. The most recent insider transaction that took place on Mar 13 ’25, was worth 76,247. In this transaction President and CFO of this company sold 4,501 shares at a rate of $16.94, taking the stock ownership to the 72,343 shares. Before that another transaction happened on Nov 26 ’24, when Company’s 10% Owner bought 48,770 for $25.83, making the entire transaction worth $1,259,623. This insider now owns 1,717,127 shares in total.
Neurogene Inc (NGNE) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -7.96% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -8.29% during the next five years compared to -10.74% drop over the previous five years of trading.
Neurogene Inc (NASDAQ: NGNE) Trading Performance Indicators
You can see what Neurogene Inc (NGNE) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 20.84. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 176.59.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.60, a number that is poised to hit -1.06 in the next quarter and is forecasted to reach -5.18 in one year’s time.
Technical Analysis of Neurogene Inc (NGNE)
The latest stats from [Neurogene Inc, NGNE] show that its last 5-days average volume of 0.63 million was superior to 0.27 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 45.50%. Additionally, its Average True Range was 1.61.
During the past 100 days, Neurogene Inc’s (NGNE) raw stochastic average was set at 12.75%, which indicates a significant decrease from 42.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 201.05% in the past 14 days, which was higher than the 147.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.57, while its 200-day Moving Average is $30.46. Now, the first resistance to watch is $11.95. This is followed by the second major resistance level at $12.89. The third major resistance level sits at $14.37. If the price goes on to break the first support level at $9.52, it is likely to go to the next support level at $8.05. Assuming the price breaks the second support level, the third support level stands at $7.10.
Neurogene Inc (NASDAQ: NGNE) Key Stats
There are 14,930K outstanding shares of the company, which has a market capitalization of 164.23 million. As of now, sales total 930 K while income totals -75,140 K. Its latest quarter income was 0 K while its last quarter net income were -20,220 K.
